Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a phase 2/3 clinical study of HLX43 for injection, according to a Thursday Hong Kong bourse filing.
The drug is being tested as monotherapy or in combination with pimurutamab HLX07 versus docetaxel for the treatment of advanced/metastatic squamous non-small cell lung cancer in patients whose prior treatment failed in the Chinese Mainland.
Tianyang New Materials (Shanghai) Technology (SHA:603330) will transfer its entire stake in Jiangsu Defarui New Materials Technology to Changshu Zhengtai Textile, according to a Thursday filing with the Shanghai bourse.The parties will still negotiate the acquisition price.Zhengtai will pay a deposit of 30 million yuan to the listed company prior to due diligence, and will pay a due diligence deposit of 10 million yuan upon signing.Jiangsu Defarui New Material Technology develops automotive interior fabrics, as well as curtains, composite, and clothing fabrics, among others.
Wuhu Token Sciences' (SHE:300088) unit, Wuhu Changxin Intelligent Computing Technology, plans to purchase servers from multiple suppliers for up to 3 billion yuan, according to a Shenzhen bourse filing on Thursday.The servers will be mainly used for providing computing power services to customers.
ByteDance is building its own central processing units to help support growing artificial intelligence hardware needs, Reuters reported Thursday, citing three people familiar with the matter.The move by TikTok's owner will help the company cope with surging chip prices and supply shortages, the newswire said.ByteDance's action signifies a shift toward "inference," where AI models perform agentic or autonomous tasks that demand more power from CPUs, the report said.The company will deploy its proprietary CPU in its own servers and data centers as it looks to roll out its Coze agent-based platform, the report said, citing one of the sources.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)